DiagnoCure - Empowering Oncology Decisions
  • Français
  • Site Map
  • Glossary
  • Contact Us
  • Home
  • Career
    • A Career of Passion
    • Talent Wanted
  • Customer
    Service
  • Products and Projects
    • Overview
    • Highlights on Cancer
    • Molecular Diagnostics
    • Bladder Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Breast Cancer
    • Other R&D Projects
    • Therapeutic Applications
  • News and
    Events
    • Overview
    • Press Releases - DiagnoCure
    • Press Releases - DiagnoCure Oncology Laboratories
    • Events
    • Awards
    • News Alerts
    • Media Room
  • Investors
    • Message to Shareholders
    • Financial Information
    • Management
    • Press Releases
    • Presentations and Conferences
    • Analysts
    • Corporate Governance
    • Investors Contact
  • About
    DiagnoCure
    • Mission and History
    • Board of Directors
    • Management
    • Intellectual Property

Site Map

About DiagnoCure

  • Mission and History
  • Board of Directors
  • Management
  • Intellectual Property

Investors

  • Message to Shareholders
  • Financial Information
  • Management
  • Press Releases
  • Presentations and Conferences
  • Analysts
  • Corporate Governance
  • Investors and Medias Contact

News and Events

  • Overview
  • Press Releases
  • Events
  • Awards
  • News Alerts
  • Media Room

Customer Service

Career

  • A Career of Passion
  • Talent Wanted

Products and Projects

  • Overview
  • Highlights on Cancer
  • Molecular Diagnostics
  • Bladder Cancer
    • Overview of Bladder Cancer
    • FAQ on Bladder Cancer
    • ImmunoCyt™/uCyt+™
      • Summary of Procedure
      • FAQ on ImmunoCyt™/uCyt+™
      • Certification
      • ImmunoCyt™/uCyt+™ Newsletter
    • Distribution Network
    • Certified Laboratories
    • Scientific Publications
  • Prostate Cancer
    • Prostate Cancer FAQ
    • PCA3 Test for Healthcare Practitioners
    • PCA3 Test for Patients
    • Market Availability
    • Scientific Publications
  • Colorectal Cancer
    • Colorectal Cancer FAQ
    • Previstage™ GCC Staging Test
    • GCC Monitoring Blood Test
    • Scientific Publications
  • Breast Cancer
  • Other R&D Projects
  • Therapeutic Applications
 
 
 

2050 René-Lévesque Blvd W., 6th floor, Québec QC G1V 2K8 CAN

T: (418) 527-6100   F: (418) 527-0240   Toll-free: 1-888-900-6626 (Canada and USA)   communications@diagnocure.com

Terms of Use